Literature DB >> 33371882

Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.

Anikó Balogh1,2, Tibor Milibák2, Viktória Szabó1, Zoltán Zsolt Nagy1, Kai Kaarniranta3, Miklós D Resch4.   

Abstract

BACKGROUND: The purpose of the study was to explore the immunological components that are responsible for the proliferative alterations in the different forms of retinal detachment (RD).
METHODS: Vitreous fluids were collected during 23G pars plana vitrectomy from 54 eyes of 54 patients with different RD types, such as rhegmatogenous RD (RRD) without proliferative vitreoretinopathy (PVR) (n = 30), PVR (n = 16) and proliferative diabetic retinopathy (PDR) with tractional RD (n = 8). Vitreous fluids were obtained from 19 eyes with epiretinal membrane (ERM), which were used as control samples. A multiplex chemiluminescent immunoassay was performed to evaluate the concentrations of 48 cytokines, chemokines and growth factors.
RESULTS: The expression levels of eotaxin, IFN-gamma, IL-6, IL-8, IL-16, MCP-1, MIF and MIP-1 beta were significantly higher in all RD groups than in the ERM group. The levels of CTACK, IP-10, SCGF-beta, and SDF-1 alpha were significantly higher in patients with diabetic tractional RD and PVR than in other patients. The upregulation of VEGF and IL-18 was detected in PDR.
CONCLUSIONS: Our results indicate that complex and significant immunological mechanisms are associated with the pathogenesis of different forms of RD: selected cytokines, chemokines and growth factors are upregulated in the vitreous of eyes with RD. The detected proteins are present in different concentrations both in RRD and PVR. In the presence of PVR and PDR, the majority of cytokines are upregulated; thus, they may serve as biomarkers to estimate the progression or severity level of proliferation and later to develop personalized therapeutic strategies to slow down or prevent pathological changes.

Entities:  

Keywords:  Chemokine; Cytokine; Proliferative diabetic retinopathy; Proliferative vitreoretinopathy; Retinal detachment; Vitreous

Year:  2020        PMID: 33371882      PMCID: PMC7768644          DOI: 10.1186/s12886-020-01745-x

Source DB:  PubMed          Journal:  BMC Ophthalmol        ISSN: 1471-2415            Impact factor:   2.209


  5 in total

1.  Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.

Authors:  Ahmed M Abu El-Asrar; Sofie Struyf; Dustan Kangave; Karel Geboes; Jo Van Damme
Journal:  Eur Cytokine Netw       Date:  2006-09       Impact factor: 2.737

2.  Interleukin-6 receptor blockade suppresses subretinal fibrosis in a mouse model.

Authors:  Wei Cui; Han Zhang; Zhe-Li Liu
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

3.  Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy.

Authors:  D J Kauffmann; J C van Meurs; D A Mertens; E Peperkamp; C Master; M E Gerritsen
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-03       Impact factor: 4.799

4.  Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment.

Authors:  Ying Dai; Zhifeng Wu; Huiming Sheng; Zhengwei Zhang; Mengxi Yu; Qing Zhang
Journal:  Mol Vis       Date:  2015-04-10       Impact factor: 2.367

5.  Identification of chemokines and growth factors in proliferative diabetic retinopathy vitreous.

Authors:  Ying Dai; Zhifeng Wu; Feng Wang; Zhengwei Zhang; Mengxi Yu
Journal:  Biomed Res Int       Date:  2014-10-27       Impact factor: 3.411

  5 in total
  1 in total

Review 1.  Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis.

Authors:  Ryan H Mason; Samuel A Minaker; Gabriela Lahaie Luna; Priya Bapat; Armin Farahvash; Anubhav Garg; Nishaant Bhambra; Rajeev H Muni
Journal:  Eye (Lond)       Date:  2022-06-07       Impact factor: 4.456

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.